A biological preparation made from killed or weakened microorganisms is known as vaccine. It consists of an agent that resembles with a disease-causing microorganism. The H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease in human beings commonly referred to as swine flu. The H1N1 virus mainly affects the respiratory system, including the nose, lungs, and throat of the infected person. The virus has caused a worldwide pandemic in the recent years. The H1N1 virus can be classified on the basis of antigenicity of its surface glycoproteins hemagglutinin and neuraminidase. Hemagglutinin helps the virus bind to host cell receptors. This simplifies viral entry into the host cell. The neuraminidase protein enzymatically splits terminal sialic acid residues from mucins, thereby letting the virus reach underlying cells in the respiratory tract. H1N1 vaccines are administered for active immunization against the H1N1 influenza virus. A major driver of the global H1N1 vaccines market is a rise in the incidence of infections across the globe. According to the World Health Organization’s 2018 factsheet estimates, 290,000 to 650,000 deaths are reported each year from all types of influenza infections (including influenza A i.e. H1N1). Worldwide, around 3 to 5 million cases  of severe viral influenza infections are diagnosed each year. Rise in awareness among physicians and end-users about disease preventation and government initiatives towards reforming health are likely to boost the market in the coming years. Moreover, a strong clinical pipeline of H1N1 vaccines further contributes to the growth of the market. However, a lack of awareness and stringent regulations hinder the growth of the global H1N1 vaccines market. 

The global H1N1 vaccines market can be segmented based on vaccine, route of administration, distribution channel, and geography. Based on vaccine, the market can be classified into inactivated vaccine and live attenuated vaccine. In terms of route of administration, the global H1N1 vaccines market can be categorized into parentral and nasal. Based on distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.

Based on geography, the global H1N1 vaccines market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe lead the global H1N1 vaccines market in terms of revenue. This is primarily due to developed research infrastructure  and increased awareness among end-users in these regions. The H1N1 vaccines market in Asia Pacific is expected to expand at a high growth rate during the forecast period, due to a rise in cases of H1N1 virus infections in the region, particularly in India and China. Moreover, an increase in awareness among the masses about diseases and increase in government initiatives and programs to raise awareness among people about various infectious diseases in Asia Pacifc are likely to boost the market in the region. There has been a significant rise in demand for H1N1 vaccines for the prevention of swine flu. Furthermore, several companies are constructing their manufacturing and research facilities in developing regions due to availability of a large patientpool, low wages, and less stringent environment and health and safety regulations. Development of medical infrastructure, growth of economies in developing countries such as India and China, discovery of new vaccines with greater efficiency, and advancements in the field of biomedical science are expected to offer attractive opportunities to players in the H1N1 vaccines market in Asia Pacific. Frequent strategic collaborations and mergers between manufacturing companies and government associations as well as product launches are the current trends in the global H1N1 vaccines market. 

Some of the major players operating in the global H1N1 vaccines market are Medimmune, GlaxoSmithKline, AstraZeneca plc, Novartis, Sanofi AG. Sinovac, Baxter, Commonwealth Serum Laboratories, Zydus Cadila, and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


H1n1 Vaccines Market

Pre Book